The importance of IL-6 blockade beyond the COVID-19 pandemic: Consideration for cancer care.
作者信息
Iorio Giuseppe Carlo, Ricardi Umberto, Franco Pierfrancesco
机构信息
Department of Oncology, Radiation Oncology, University of Turin, Italy.
Department of Oncology, Radiation Oncology, University of Turin, Italy.
出版信息
Radiother Oncol. 2020 Oct;151:24-25. doi: 10.1016/j.radonc.2020.07.018. Epub 2020 Jul 13.
Abstract
摘要
相似文献
1
The importance of IL-6 blockade beyond the COVID-19 pandemic: Consideration for cancer care.白细胞介素-6阻断在新冠疫情之外的重要性：对癌症治疗的考量
Radiother Oncol. 2020 Oct;151:24-25. doi: 10.1016/j.radonc.2020.07.018. Epub 2020 Jul 13.
2
Oral cancer and ACE2 receptor of SARS-CoV-2.口腔癌与新型冠状病毒2的血管紧张素转换酶2受体
Oral Oncol. 2020 Sep;108:104920. doi: 10.1016/j.oraloncology.2020.104920. Epub 2020 Jul 21.
3
COVID alias challenge to onco-rehabilitation and to viable indications and decisions: Cues from an Italian COVID+ oral cancer patient.新冠疫情对肿瘤康复及可行的适应症与决策构成的挑战：来自一名意大利新冠阳性口腔癌患者的线索
Oral Oncol. 2020 Jun;105:104745. doi: 10.1016/j.oraloncology.2020.104745. Epub 2020 Apr 24.
4
Virtual assistance in oral medicine for prioritizing oral cancer diagnosis during the COVID-19 pandemic.在新冠疫情期间，口腔医学中的虚拟辅助用于优先进行口腔癌诊断。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2020 Jul;130(1):127-128. doi: 10.1016/j.oooo.2020.04.009. Epub 2020 Apr 18.
5
Methotrexate based oral chemotherapy for advanced oral cancer during COVID-19 pandemic: Another option in the therapeutic armamentarium.在新冠疫情期间，基于甲氨蝶呤的口服化疗用于晚期口腔癌：治疗手段中的另一种选择。
Oral Oncol. 2020 Aug;107:104839. doi: 10.1016/j.oraloncology.2020.104839. Epub 2020 Jun 4.
6
The Kerala Model of health care delivery and its impact on Oral cancer care during the COVID 19 pandemic.喀拉拉邦的医疗保健提供模式及其对 COVID-19 大流行期间口腔癌护理的影响。
Oral Oncol. 2020 Jul;106:104769. doi: 10.1016/j.oraloncology.2020.104769. Epub 2020 May 3.
7
Early oral cancer management during the COVID-19 period.COVID-19 期间早期口腔癌的管理
Br J Oral Maxillofac Surg. 2020 Oct;58(8):885-887. doi: 10.1016/j.bjoms.2020.06.043. Epub 2020 Aug 13.
8
Virtual Cancer Care During and Beyond the COVID-19 Pandemic: We Need to Get It Right.2019冠状病毒病大流行期间及之后的虚拟癌症护理：我们必须做好。
JCO Oncol Pract. 2020 Sep;16(9):527-529. doi: 10.1200/OP.20.00281. Epub 2020 May 13.
9
Inhibiting IL-6 in COVID-19: we are not sure.在新冠肺炎中抑制白细胞介素-6：我们并不确定。
Crit Care. 2020 Jul 27;24(1):463. doi: 10.1186/s13054-020-03177-x.
10
IL-6 may be a good biomarker for earlier detection of COVID-19 progression.白细胞介素-6可能是早期检测新型冠状病毒肺炎病情进展的良好生物标志物。
Intensive Care Med. 2020 Jul;46(7):1475-1476. doi: 10.1007/s00134-020-06065-8. Epub 2020 May 8.
引用本文的文献
1
A German AWMF's S2e/realist synthesis and meta-narrative snapshot of craniomaxillofacial manifestations in COVID-19 patients: Rapid living update on 1 January 2021.德国 AWMF 的 S2e/真实主义综合和 COVID-19 患者颅颌面表现的元叙事快照：2021 年 1 月 1 日快速实时更新。
J Stomatol Oral Maxillofac Surg. 2022 Feb;123(1):64-73. doi: 10.1016/j.jormas.2021.01.012. Epub 2021 Jan 30.
本文引用的文献
1
COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO).意大利 COVID-19 疫情爆发及癌症放疗中断：意大利放射治疗和临床肿瘤学协会（AIRO）认可的调查。
Radiother Oncol. 2020 Aug;149:89-93. doi: 10.1016/j.radonc.2020.04.061. Epub 2020 May 12.
2
Radiation therapy during the coronavirus disease 2019 (covid-19) pandemic in Italy: a view of the nation's young oncologists.意大利2019冠状病毒病（COVID-19）大流行期间的放射治疗：该国年轻肿瘤学家的观点。
ESMO Open. 2020 Apr;5(2). doi: 10.1136/esmoopen-2020-000779.
3
COVID-19: consider cytokine storm syndromes and immunosuppression.2019冠状病毒病：考虑细胞因子风暴综合征和免疫抑制。
Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.
4
Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1.与严重急性呼吸综合征冠状病毒1（SARS-CoV-1）相比，严重急性呼吸综合征冠状病毒2（SARS-CoV-2）在气溶胶和表面的稳定性
N Engl J Med. 2020 Apr 16;382(16):1564-1567. doi: 10.1056/NEJMc2004973. Epub 2020 Mar 17.
5
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.基于对来自中国武汉的150名患者数据的分析得出的COVID-19相关死亡的临床预测因素。
Intensive Care Med. 2020 May;46(5):846-848. doi: 10.1007/s00134-020-05991-x. Epub 2020 Mar 3.
6
Tumour microenvironment of pancreatic cancer: immune landscape is dictated by molecular and histopathological features.胰腺癌的肿瘤微环境：免疫景观由分子和组织病理学特征决定。
Br J Cancer. 2019 Jul;121(1):5-14. doi: 10.1038/s41416-019-0479-5. Epub 2019 May 21.
7
Targeting the IL-6/JAK/STAT3 signalling axis in cancer.针对癌症中的 IL-6/JAK/STAT3 信号通路。
Nat Rev Clin Oncol. 2018 Apr;15(4):234-248. doi: 10.1038/nrclinonc.2018.8. Epub 2018 Feb 6.
8
IL-6 controls resistance to radiation by suppressing oxidative stress via the Nrf2-antioxidant pathway in oral squamous cell carcinoma.白细胞介素-6通过Nrf2-抗氧化途径抑制氧化应激来控制口腔鳞状细胞癌对辐射的抗性。
Br J Cancer. 2016 Nov 8;115(10):1234-1244. doi: 10.1038/bjc.2016.327. Epub 2016 Oct 13.
9
Interleukin-6 as a therapeutic target.白细胞介素 6 作为治疗靶点。
Clin Cancer Res. 2015 Mar 15;21(6):1248-57. doi: 10.1158/1078-0432.CCR-14-2291. Epub 2015 Jan 14.
10
Radiation as an immunological adjuvant: current evidence on dose and fractionation.辐射作为一种免疫佐剂：目前关于剂量和分割的证据。
Front Oncol. 2012 Oct 26;2:153. doi: 10.3389/fonc.2012.00153. eCollection 2012.
Zotero 插件